BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 8097018)

  • 21. Molecular biology of Beckwith-Wiedemann syndrome.
    Weksberg R; Squire JA
    Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxation of imprinting of human insulin-like growth factor II gene, IGF2, in sporadic breast carcinomas.
    Wu HK; Squire JA; Catzavelos CG; Weksberg R
    Biochem Biophys Res Commun; 1997 Jun; 235(1):123-9. PubMed ID: 9196048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
    Taniguchi T; Okamoto K; Reeve AE
    Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
    Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
    Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
    Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
    Weksberg R; Shen DR; Fei YL; Song QL; Squire J
    Nat Genet; 1993 Oct; 5(2):143-50. PubMed ID: 8252039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
    Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
    Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.
    Satoh Y; Nakadate H; Nakagawachi T; Higashimoto K; Joh K; Masaki Z; Uozumi J; Kaneko Y; Mukai T; Soejima H
    Br J Cancer; 2006 Aug; 95(4):541-7. PubMed ID: 16909133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
    Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Oswald M; Lausch E; Schmidtke P; Reutzel D; Fees S; Lucito R; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4085-90. PubMed ID: 15743916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain.
    Cooper PR; Smilinich NJ; Day CD; Nowak NJ; Reid LH; Pearsall RS; Reece M; Prawitt D; Landers J; Housman DE; Winterpacht A; Zabel BU; Pelletier J; Weissman BE; Shows TB; Higgins MJ
    Genomics; 1998 Apr; 49(1):38-51. PubMed ID: 9570947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.
    Kondo M; Suzuki H; Ueda R; Osada H; Takagi K; Takahashi T; Takahashi T
    Oncogene; 1995 Mar; 10(6):1193-8. PubMed ID: 7700644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer.
    Yun K; Fukumoto M; Jinno Y
    Am J Pathol; 1996 Apr; 148(4):1081-7. PubMed ID: 8644850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
    Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
    Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beck-Wiedemann syndrome and Wilms' tumour.
    Ward A
    Mol Hum Reprod; 1997 Feb; 3(2):157-68. PubMed ID: 9239720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental regulation of genomic imprinting of the IGF2 gene in human liver.
    Davies SM
    Cancer Res; 1994 May; 54(10):2560-2. PubMed ID: 8168079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome.
    Schneid H; Vazquez MP; Seurin D; le Bouc Y
    Growth Regul; 1991 Dec; 1(4):168-70. PubMed ID: 1688177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.